We are live on !
Find out more
Emerald Mutual Fund Advisers Trust Portfolio holdings
AUM
$2.85B
Turnover
25.55%
1-Year Est. Return
140.52%
This Fund
S&P 500
This Quarter Est. Return
+50.07%
1 Year Est. Return
+140.52%
3 Year Est. Return
+478.17%
5 Year Est. Return
+660.56%
10 Year Est. Return
+4,974.42%
AUM
$2.85B
AUM Growth
+$784M
(+38%)
Cap. Flow
+$29M
Cap. Flow % of AUM
Cap. Flow %
1.02%
Top 10 Holdings %
Top 10 Hldgs %
18.45%
Holding
227
New
28
Increased
83
Reduced
39
Closed
30
Avg Time Held
1.7
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Legence Corp
LGN
|
+$34.7M |
| 2 |
Sensient Technologies
SXT
|
+$26.2M |
| 3 |
InterDigital
IDCC
|
+$26M |
| 4 |
Axcelis
ACLS
|
+$25.5M |
| 5 |
Terex
TEX
|
+$22.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bloom Energy
BE
|
+$89.9M |
| 2 |
Credo Technology Group
CRDO
|
+$58.4M |
| 3 |
TTM Technologies
TTMI
|
+$52.9M |
| 4 |
Fabrinet
FN
|
+$33.9M |
| 5 |
Modine Manufacturing
MOD
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.21% |
| 2 | Industrials | 22.3% |
| 3 | Healthcare | 21.59% |
| 4 | Financials | 10.79% |
| 5 | Consumer Discretionary | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
F/m Emerald Life Sciences Innovation ETF
LFSC
$118M
| $90.3M | 3.17% |
1,997,035
| – | – |
2025 Q2
4 quarters
|
|
2
Travere Therapeutics
TVTX
$5B
| $58.6M | 2.06% |
1,032,024
+86,991
| +9% | +$3.86M |
2023 Q2
12 quarters
|
|
3
Cardinal Infrastructure Group
CDNL
$313M
| $51.7M | 1.82% |
549,297
+190,234
| +53% | +$10.9M |
2025 Q4
2 quarters
|
|
4
Mercury Systems
MRCY
$4.59B
| $50.4M | 1.77% |
412,354
+36,882
| +10% | +$3.51M |
2025 Q2
4 quarters
|
|
5
AAR Corp
AIR
$4.02B
| $48.2M | 1.69% |
337,416
+57,159
| +20% | +$6.75M |
2022 Q4
14 quarters
|
|
6
VSE Corp
VSEC
$4.32B
| $47.9M | 1.68% |
209,628
+13,713
| +7% | +$2.63M |
2025 Q1
5 quarters
|
|
7
Kulicke & Soffa
KLIC
$4.26B
| $46.7M | 1.64% |
349,295
| – | – |
2023 Q3
11 quarters
|
|
8
Argan
AGX
$4.82B
| $46.4M | 1.63% |
58,115
-828
| -1% | -$551K |
2025 Q3
3 quarters
|
|
9
Ceco Environmental
CECO
$3.45B
| $42.8M | 1.5% |
471,220
+157,215
| +50% | +$12.4M |
2025 Q3
3 quarters
|
|
|
10
InterDigital
IDCC
$8.6B
| $42M | 1.48% |
148,255
+87,579
| +144% | +$26M |
2024 Q1
9 quarters
|
|
11
Semtech
SMTC
$13.2B
| $41.7M | 1.46% |
257,359
-27,678
| -10% | -$3.62M |
2025 Q3
3 quarters
|
|
|
12
Axcelis
ACLS
$3.58B
| $41.6M | 1.46% |
219,443
+172,031
| +363% | +$25.5M |
2026 Q1
1 quarter
|
|
13
ESCO Technologies
ESE
$6.41B
| $40.8M | 1.43% |
116,457
+17,955
| +18% | +$5.62M |
2025 Q2
4 quarters
|
|
14
Guardant Health
GH
$22.7B
| $40.7M | 1.43% |
271,380
-248,165
| -48% | -$27M |
2025 Q1
5 quarters
|
|
15
LivaNova
LIVN
$4.31B
| $40.5M | 1.42% |
492,868
+38,539
| +8% | +$2.73M |
2023 Q1
13 quarters
|
|
16
Plexus
PLXS
$6.38B
| $40.5M | 1.42% |
134,746
+32,468
| +32% | +$8.47M |
2026 Q1
1 quarter
|
|
17
Corcept Therapeutics
CORT
$12.6B
| $40.4M | 1.42% |
464,902
+285,295
| +159% | +$17.2M |
2025 Q1
5 quarters
|
|
18
PDF Solutions
PDFS
$1.85B
| $40.1M | 1.41% |
566,429
-28,181
| -5% | -$1.4M |
2022 Q2
16 quarters
|
|
19
Cogent Biosciences
COGT
$5.46B
| $39.9M | 1.4% |
1,031,378
+2,546
| +0.2% | +$89.1K |
2025 Q2
4 quarters
|
|
20
Cohu
COHU
$2.63B
| $39.4M | 1.39% |
533,619
+43,769
| +9% | +$2.19M |
2026 Q1
1 quarter
|
|
21
Allegiant Air
ALGT
$1.9B
| $36.9M | 1.3% |
313,661
+101,836
| +48% | +$8.81M |
2024 Q4
6 quarters
|
|
|
22
Legence Corp
LGN
$3.2B
| $36.3M | 1.27% |
+425,628
| New | +$34.7M |
2026 Q2
0 quarters
|
|
23
Axos Financial
AX
$5.07B
| $35.7M | 1.26% |
366,712
+29,972
| +9% | +$2.7M |
2021 Q2
20 quarters
|
|
24
Spyre Therapeutics
SYRE
$8.68B
| $35.6M | 1.25% |
401,271
-6,842
| -2% | -$499K |
2024 Q3
7 quarters
|
|
|
25
Modine Manufacturing
MOD
$8.01B
| $35M | 1.23% |
131,187
-104,884
| -44% | -$27.6M |
2024 Q2
8 quarters
|
|
Similar funds
Emerald Mutual Fund Advisers Trust's Q2 2026 Portfolio in Review
As of Q2 2026, Emerald Mutual Fund Advisers Trust held 227 positions worth $2.85B, up 38% from $2.06B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Emerald Mutual Fund Advisers Trust's Q2 2026 filing shows 28 new, 83 increased, 39 reduced and 30 closed positions. Its largest new stake was Legence Corp: 425,628 shares worth $36.3M. The largest sale was Bloom Energy, an estimated $89.9M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.
- Emerald Mutual Fund Advisers Trust's largest Q2 2026 buy was Legence Corp: 425,628 shares worth $36.3M.
- Emerald Mutual Fund Advisers Trust added most to InterDigital in Q2 2026, an estimated $26M increase.
- Emerald Mutual Fund Advisers Trust's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $89.9M.
- Emerald Mutual Fund Advisers Trust fully exited Fabrinet in Q2 2026, selling an estimated $33.9M.
- Emerald Mutual Fund Advisers Trust's ten largest holdings make up 18% of its $2.85B portfolio in Q2 2026.
- Emerald Mutual Fund Advisers Trust opened 28 new positions and closed 30 in Q2 2026.
- Emerald Mutual Fund Advisers Trust's portfolio value rose 38% quarter-over-quarter to $2.85B.
Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2026, filed 5 Aug 2026.